Dr. Gail Roboz spoke to a U.S. FDA panel about the benefits of imetelstat as a treatment option for transfusion-dependent anemia in certain myelodysplastic syndrome (#MDS) patients: bit.ly/3PoX5Ax

#Cancer can have a big impact on #BoneHealth. In this episode of #CancerCast, Penny Andreopoulou breaks down everything patients need to know about the connection between the bones and cancer, incl. how diagnosis & treatment can directly affect bone strength bit.ly/3vrQcYt

The Weill Cornell Medicine NewYork-Presbyterian #Leukemia team is proud to support #AMLWorldAwarenessDay. We are dedicated to raising awareness and advancing care for all patients, caregivers, and loved ones impacted by #AcuteMyeloidLeukemia (#AML). @Know_AML #KnowAML

A Good Morning America segment with Dr. Gail Roboz led Stacy to seek a second opinion Weill Cornell Medicine NewYork-Presbyterian. On #AMLWorldAwarenessDay, learn more about Stacy’s #AcuteMyeloidLeukemia care from Dr. Roboz, Dr. Tsiporah Shore and the bone marrow donor who helped save her life bit.ly/3JnopLZ

#DYK that #Pathology supplies a majority of a medical record? On #CancerCast, Dr. Amy Chadburn of Weill Cornell Medicine Pathology explains the role pathologists play in #cancer care to help solid tumor & #BloodCancer patients get accurate diagnoses and treatment plans: bit.ly/3JF7ViE

This #ClinicalTrialsDay, team members Weill Cornell Medicine NewYork-Presbyterian highlight how we’re making a difference through #ClinicalTrials. So proud of the #ClinicalResearch and behind-the-scenes teamwork moving the field forward. Thanks to all the volunteers who participate in #research!

Congratulations to second-year fellow Dr. Joshua Fein for being selected as one of 17 ASH RTAF Award recipients!

Why should you participate in your #AML care and treatment decisions? Dr. Gail Roboz of Weill Cornell Leukemia shares expert perspective. ow.ly/y9v450SqUi2 #bloodcancer #AMLsm #genetictests #FLT3 #IDH #leusm #leukemia

Dr. Gail Roboz sat down with other experts at the International Consortium for MDS (icMDS) #iwMDS to discuss therapy options for the treatment of high-risk #MyelodysplasticSyndromes (#MDS): bit.ly/3Wey3a0 #mdssm

Excited to share this publication !! Congratulations to all my collaborators Alex Bick Michael Honigberg, MD, MPP , Paul Auer, Ying Zhou , Alex Reiner, JoAnn Manson , Samuel Handelman among many others!! Weill Cornell Leukemia WCM Englander Institute for Precision Medicine

Our ASCO #CancerCast tradition continues! Dr. Manish Shah (Manish A. Shah) joined me for our annual episode where we delve into the most exciting #ASCO24 #research. From #AI to #immunotherapy & #BiTes, we break down what patients and loved ones should know bit.ly/3WNlPql

Dr. Gail Roboz joined Patient Empowerment Network for a video series on acute myeloid #leukemia (#AML) treatments and treatment decisions. In the first video, she breaks down the importance of patients advocating for themselves with their care team: bit.ly/3WFwpQ1

In part 2 of Dr. Gail Roboz’s video series with Patient Empowerment Network, learn more about how acute myeloma #leukemia (#AML) treatment decisions are made: bit.ly/4c5WcFF

WATCH: Dr. Gail Roboz discusses the types of tests that occur after an acute myeloid #leukemia (#AML) diagnosis in part 3 of her video series with Patient Empowerment Network bit.ly/3YrDB3t

What are the treatment options and phases of therapy for acute myeloid #leukemia (#AML)? Dr. Gail Roboz outlines the options via Patient Empowerment Network: bit.ly/3LGwigK

In another Patient Empowerment Network video, Dr. Gail Roboz speaks about inhibitor therapies for acute myeloid #leukemia (#AML): bit.ly/4c5DYDW

Watch Dr. Gail Roboz explain what patients with acute myeloid #leukemia (#AML) need to know about test results in this Patient Empowerment Network video: bit.ly/3WGFLLe

WATCH: Pinkal Desai discusses how to understand risk stratification and treatment options available for patients with #MyelodysplasticSyndrome (#MDS) via #GDUHEM. bit.ly/4cJmoWS

.Pinkal Desai spoke with colleagues as part of a case-based roundtable event with Targeted Oncology about how blastic plasmacytoid dendritic cell neoplasm (BPDCN) differs from other types of #BloodCancers like #leukemia and #lymphoma: bit.ly/4cH3LTa

Great to see this published ! Understanding cardiotoxicity from MCL inhibition is important Thanks to all the investigators that made this possible. And AstraZeneca for the commitment to publish ! AstraZeneca Weill Cornell Leukemia James Blachly Clinical Cancer Research aacrjournals.org/clincancerres/…